Ad4-PA-GPI-1 (Emergent BioSolutions)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAd4-PA-GPI-1 (Emergent BioSolutions)
Drug Alias NameAd4-PA-GPI (glycosylphosphatidylinositol)-1 vaccineAd4-PA-GPI-1
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmergent Biosolutions Inc
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A